GlobalGov › Germany › Solicitation

Germany – Administrative healthcare services – Vertrag zur besonderen Versorgung gem. § 140a SGB V zur Behandlung von Patienten mittels intravitrealer Medikamenteneingabe von VEGF-Hemmern (IVI) in Schleswig-Holstein und Hamburg

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

October 30, 2029
Response Due
Active
Status

Opportunity Overview

Germany – Administrative healthcare services – Contract for special care pursuant to Section 140a of the German Social Code, Book V (SGB V), for the treatment of patients by means of intravitreal injection of VEGF inhibitors (IVI) in Schleswig-Holstein and Hamburg

This is one of 1,752 active Germany Health Services opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryHealth Services
PublishedNovember 25, 2025
Procurement stageActive solicitation
Response dueOctober 30, 2029
StatusOpen — accepting responses
TranslationTranslated from German by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Browse all categories →

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Sulfasalazin (M01CX02) im Rahmen eines sogenannten Open-House-Modells.
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Eltrombopag, ATC B02BX05
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Epoetin zeta
Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Timolol und Latanoprost (ATC-Code: S01ED61 - außer Normpackungsgrößen N1-N3)
Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-09
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sarilumab, ATC L04AC14
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nitrendipin, ATC C08CA08
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rasagilin, ATC N04BD02

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.